M&A Deal Summary |
|
---|---|
Date | 2024-12-06 |
Target | Motif Labs |
Sector | Consumer Products |
Buyer(s) | Organigram Holdings |
Deal Type | Add-on Acquisition |
Deal Value | 90M USD |
Advisor(s) | Jefferies (Financial) Davies Ward Phillips & Vineberg (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2010 |
Sector | Consumer Products |
Employees | 914 |
Revenue | 146M CAD (2022) |
Organigram Holdings is a producer of cannabis and cannabis-derived products in Canada and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused soft chews in Canada. Organigram Holdings was founded in 2010 and is based in Moncton, New Brunswick.
DEAL STATS | # |
---|---|
Overall | 4 of 4 |
Sector (Consumer Products) | 3 of 3 |
Type (Add-on Acquisition) | 2 of 2 |
State (Ontario) | 1 of 1 |
Country (Canada) | 3 of 3 |
Year (2024) | 2 of 2 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-06-25 |
Sanity Group
Berlin, Germany Sanity Group improves people’s quality of life through the use of cannabinoids and the endocannabinoid system. In addition to pharmaceuticals, the focus is also on well-being and cosmetic products that utilize cannabinoids. The group comprises Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (minority investment in finished pharmaceuticals), and VAAY (wellbeing). Sanity Group was formed in 2018 and is based in Berlin, Germany. |
Buy | - |